Skip to content
2000
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007

Abstract

Background

This study investigated the use of polyelectrolyte complex formation by using two oppositely charged polysaccharides [Chitosan (cationic), Sodium Alginate (anionic)]. It forms 3-D intercalation and interpenetrating network helping in controlling the release of highly acid-soluble Captopril.

Objective

To develop a polyelectrolyte complex based single unit gastroretentive tablet by using optimization based 3 (2) Taguchi factorial design for controlled delivery of Captopril.

Materials and Methods

Gastroretentive Captopril tablets were prepared by the direct compression technique. Total 09 batches were prepared as per 3 (2) Taguchi factorial design studies of 100 tablets each.

Results

Thermal analysis method revealed that there is a formation of PEC between chitosan and sodium alginate. buoyancy and T, drug release studies revealed that due to complex formation, formulation remains stable and remains buoyant. From factorial design studies, it was interpreted that for buoyancy time (Y) chitosan desired effect value was found higher. For 60% drug release (T; Y) both chitosan and sodium alginate have a synergistic effect. Durbin Watson's statistical model and residual data suggested that the model is statistically validated. All formulations follow the zero-order kinetics. Stability studies revealed that formulations F5 and F9 remain stable for long-term stability studies without showing any significant changes. The fit analysis studies indicated that the prepared formulation was different from the innovator product indicating low and values.

Conclusion

From the result generated it was concluded that chitosan-sodium alginate polyelectrolyte complex has sufficient potential to retard the release of CPT.

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/2210299X01666230808152133
2023-10-11
2025-04-06
The full text of this item is not currently available.

References

  1. TripathiK.D. Essentials of Medical Pharmacology.8th International EditionJP Medical Ltd2018483484
    [Google Scholar]
  2. SathishD. HimabinduS. KumarP. RaoY. Preparation and evaluation of novel expandable drug delivery system with captopril.Curr. Drug Ther.20148320621410.2174/1574885508666131203001213
    [Google Scholar]
  3. ShanthiC.N. GuptaR. MahatoA.K. A review on captopril oral sustained/controlled release formulations.Int. J. Drug Dev. Res.20102257267
    [Google Scholar]
  4. AhsanM. AbbasN. HussainA. SaeedH. Akhtar ShahP. MohammadS. ArshadM.S. Formulation optimization and in-vitro evaluation of oral floating captopril matrix tablets using factorial design.Trop. J. Pharm. Res.201514101737174810.4314/tjpr.v14i10.2
    [Google Scholar]
  5. NamdevA. JainD. Floating drug delivery systems: An emerging trend for the treatment of peptic ulcer.Curr. Drug Deliv.2019161087488610.2174/156720181666619101816351931894738
    [Google Scholar]
  6. YangX. WangB. QiaoC. LiZ. LiY. XuC. LiT. Molecular interactions in N-[(2-hydroxyl)-propyl-3-trimethyl ammonium] chitosan chloride-sodium alginate polyelectrolyte complexes.Food Hydrocoll.202010010540010.1016/j.foodhyd.2019.105400
    [Google Scholar]
  7. JiangY. WangY. LiQ. YuC. ChuW. Natural polymer-based stimuli-responsive hydrogels.Curr. Med. Chem.202027162631265710.2174/092986732666619112214491631755377
    [Google Scholar]
  8. SoniS. RamV. VermaA. 3 (2) factorial design assisted crushed puffed rice-HPMC-chitosan based hydrodynamically balanced system of metoprolol succinate.Drug Deliv. Lett.2020103237249[DOI: 10.2174/2210303110999200408122629].10.2174/2210303110999200408122629
    [Google Scholar]
  9. LalN. DubeyJ. GaurP. VermaN. VermaA. Chitosan based in situ forming polyelectrolyte complexes: A potential sustained drug delivery polymeric carrier for high dose drugs.Mater. Sci. Eng. C20177949149810.1016/j.msec.2017.05.05128629045
    [Google Scholar]
  10. JagdaleS.C. RandhaveA.B. Hydroxyl ethyl cellulose hhx and polymethyl methacrylate based site specific floating delivery of prochlorperazine maleate.Open Pharm. Sci. J.20163114916310.2174/1874844901603010149
    [Google Scholar]
  11. KumarL. Sreenivasa ReddyM. ManaguliR.S. Pai KG. Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.Saudi Pharm. J.201523554955510.1016/j.jsps.2015.02.00126594122
    [Google Scholar]
  12. DurbinJ. WatsonG.S. Testing for serial correlation in least squares regression. III.Biometrika19715811910.2307/2334313
    [Google Scholar]
  13. KhanH. AliM. AhujaA. AliJ. Stability testing of pharmaceutical products: Comparison of stability testing guidelines.Curr. Pharm. Anal.20106214215010.2174/157341210791202627
    [Google Scholar]
  14. CostaP. An alternative method to the evaluation of similarity factor in dissolution testing.Int. J. Pharm.20012201-2778310.1016/S0378‑5173(01)00651‑211376969
    [Google Scholar]
  15. GuidanceF.D. Guidance for industry: Dissolution testing of immediate release solid oral dosage forms. us department of health and human services. food and drug administration, center for drug evaluation and research.CDER1997
    [Google Scholar]
  16. MoraisJ.A. LobatoM. The new EMEA guideline on the investigation of bioequivalence.Portuguese J. Pharma.200917680
    [Google Scholar]
  17. BarendsD. DressmanJ. HubbardJ. JungingerH. PatnaikR. PolliJ. StavchanskyS. Multisource (generic) Pharmaceutical Products: Guidelines on Registration Requirements to Establish.WHO, Geneva, SwitzerlandInterchangeability Draft Revision2005
    [Google Scholar]
  18. PermeabilidadC.S. AltaI.A. AltaI.B. BajaI.A. BajaI.B. National Administration of Medicines, Food and Medical Technology (ANMAT). Provision No. 3185.ArgentinaBuenos Aires1999
    [Google Scholar]
  19. VasiliuS. RacovitaS. PopaM. OchiuzL. PeptuC.A. Chitosan-based polyelectrolyte complex hydrogels for biomedical applications. In cellulose-based superabsorbent hydrogels polymers and polymeric composites: A reference series Mondal M (ed.). Springer Cham201916952510.1007/978‑3‑319‑77830‑3_56
    [Google Scholar]
  20. Pharmacopeia US. National Formulary (USP-25/NF-20). InRockville.MDUnited States Pharmacopeial Convention2000
    [Google Scholar]
  21. DasU. WadhwaP. SinghP.K. KalidindiD.V. NagpalK. The role of polymers and excipients for better gastric retention of captopril.Crit. Rev. Ther. Drug Carr.20223968510610.1615/CritRevTherDrugCarrierSyst.2022042122
    [Google Scholar]
  22. AnaiziN.H. SwensonC. Instability of aqueous captopril solutions.Am. J. Hosp. Pharm.19935034864888442468
    [Google Scholar]
  23. PatelP. DandN. SomwanshiA. KadamV.J. HirlekarR.S. Design and evaluation of a sustained release gastroretentive dosage form of captopril: A technical note.AAPS PharmSciTech20089383683910.1208/s12249‑008‑9120‑218626773
    [Google Scholar]
  24. AbdalrbG.A. MircioiuI. AmzoiuM. BeluI. AnutaV. In Vitro and In Vivo evaluation of different solid dosage forms containing captopril.Curr. Health Sci. J.201743321421930595878
    [Google Scholar]
/content/journals/cis/10.2174/2210299X01666230808152133
Loading
/content/journals/cis/10.2174/2210299X01666230808152133
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test